Biostax Corp. (BTAX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 21, 2026, 9:30 AM EST
Biostax Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
10.52K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ObsEva | 19.64M |
| GeneLink | 1.58M |
| Trevena | 546.00K |
| Syros Pharmaceuticals | 386.00K |
| Entia Biosciences | 265.47K |
| Navidea Biopharmaceuticals | 610.00 |
Biostax News
- 1 year ago - Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration - GlobeNewsWire
- 2 years ago - Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception - GlobeNewsWire
- 2 years ago - Biostax Announces a Director Appointment of Influential Business Leader Craig Suro - GlobeNewsWire
- 2 years ago - Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors - GlobeNewsWire
- 2 years ago - Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment - GlobeNewsWire